![](/img/cover-not-exists.png)
JAK2 inhibition sensitizes resistant EGFR-mutant lung adenocarcinoma to tyrosine kinase inhibitors
Gao, S. P., Chang, Q., Mao, N., Daly, L. A., Vogel, R., Chan, T., Liu, S. H., Bournazou, E., Schori, E., Zhang, H., Red Brewer, M., Pao, W., Morris, L., Ladanyi, M., Arcila, M., Manova-Todorova, K., dVolume:
9
Language:
english
Journal:
Science Signaling
DOI:
10.1126/scisignal.aac8460
Date:
March, 2016
File:
PDF, 1.26 MB
english, 2016